SAM
CHRS icon

Sagewood Asset Management’s Coherus Oncology CHRS Stock Holding History

Sagewood Asset Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,732
Closed -$20.9K – 351
2025
Q4 		$20.9K Buy
+14,732
New +$21.5K 0.01% 257

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Kohlberg Kravis Roberts & Co
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Sagewood Asset Management's CHRS Position: Q1 2026 in Review

Sagewood Asset Management sold out of Coherus Oncology (CHRS) in Q1 2026, closing a stake of 14,732 shares — an estimated $20.9K sold.

Sagewood Asset Management first reported a position in CHRS in Q4 2025 and held it in 1 quarter. The position peaked at $20.9K in Q4 2025. 158 funds tracked by Wall St. Rank hold CHRS as of Q1 2026.

  • Sagewood Asset Management reported no remaining Coherus Oncology position as of Q1 2026 after selling out during the quarter.
  • Sagewood Asset Management sold 14,732 Coherus Oncology shares in Q1 2026, an estimated $20.9K.
  • Sagewood Asset Management first reported a position in Coherus Oncology in Q4 2025 and held it in 1 quarter.
  • Sagewood Asset Management's Coherus Oncology position peaked at $20.9K in Q4 2025.
  • 158 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2026.

Based on Sagewood Asset Management's 13F filing for Q1 2026, filed 13 May 2026.